Moreover, we observed a reduced expression of HLA class II molecules (CD74, HLA-DRA, HLA-DRB1, HLA-DMA), which might affect the number and function of CD4+ T lymphocytes in the tumor microenvironment [47] (Fig. 3J). Here, HLA-DRA is linked to neoplasm.